[1]Bierhaus A, Chen J, Liliensiek B, Nawroth P P. 2000. LPS and cytokine activated endothelium. Seminars in Thrombosis and Hemostasis, 26, 571-587. [2]Brody S, Yanofsky C. 1963. Suppressor gene alteration of protein primary structure. Proceedings of National Academy of Sciences of the United States of America, 50, 9-16. [3]Chu M, Chu Z, Wang D. 2007. The extract of compound Radix Ccutellariae on mRNA replication and IFN expression of influenza virus in mice. Journal of Chinese Medicinal Materials, 1, 63-65. (in Chinese) [4]Deonarain R, Alcamí A, Alexiou M, Dallman M J, Gewert D R, Porter A C J. 2000. Impaired antiviral response and α/β interferon induction in mice lacking β interferon. Journal of Virology, 7, 3404-3409. [5]Diebold S S, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell L E, Al-Shamkhani A, Flavell R, Borrow P, Reis Sousa C. 2003. Viral infection switches nonplasmacytoid dendritic cells into high interferon producers. Nature, 6946, 324-328. [6]Dustin M L, Rothlein R, Bhan A K, Dinarello C A, Springer T A. 1986. Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). Journal of Immunology, 137, 245-254. [7]Elevy D, Adolfo G S. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine and Growth Factor Reviews, 12, 143-156. [8]Faure E, Thomas L, Xu H, Medvedev A E, Equils O, Arditi M. 2001. Bacterial lipopolysaccharide and IFN-γ induce toll-like receptor 2 and roll-like receptor 4 expression in human endothelial cells: role of NF-κB activation 1. The Journal of Immunology, 166, 2018-2024. [9]Fichtner F, Koslowski R, Augstein A, Hempel U, Röhlecke C, Kasper M. 2004. Bleomycin induces IL-8 and ICAM-1 expression in microvascular pulmonary endothelial cells. Experimental and Toxicological Pathology, 55, 497-503. [10]Goffic R L, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M. 2007. Cutting edge: influenza a virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. Journal of Immunology, 178, 3368-3372. [11]Hu G, Xue J, Duan H, Yang A, Gao L, Luo H, Mu X, Cui S. 2010. IFN-γ induces IFN-α and IFN-β expressions in cultured rat intestinal mucosa microvascular endothelial cells. Immunopharmacology and Immunotoxicology, 4, 656-662. [12]Heidemann J, Domschke W, Kucharzik T, Maaser C. 2006. Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense? Infection and Immunity, 74, 5425-5432. [13]Heron I, Hokland M, Berg K. 1978. Enhanced expression of β2 microglobulin and HLA antigens on human lymphoid cells by interferon. Proceedings of National Academy of Sciences of the United States of America, 62, 15-19. [14]Hägele H, Allam R, Pawar R D, Anders H. 2009. Doublestranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1. Nephrology Dialysis Transplantation, 24, 3312-3318. [15]Inagami T, Naruse M, Richard H. 1995. Endothelium as an endocrine organ. Annual Review of Physiology, 57, 171-189. [16]Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nature Immunology, 5, 987-995. [17]Jacobs A T, Ignarro L J. 2001. Lipopolysaccharide-induced expression of interferon-β mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. The Journal of Biological Chemistry, 51, 47950-47957. [18]Kim I W, Hwang J Y, Kim S K, Kim J K, Park H S. 2007. Interferon-stimulated genes response in endothelial cells following hantaan virus infection. Journal of Korean Medical Sciences, 22, 987-992. [19]Marelli-Berg F M, Jarmin S J. 2004. Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking? Immunology Letters, 93, 109-113. [20]Nacionales D C, Kelly K M, Lee P Y, Zhuang H, Li Y, Weinstein J S, Sobel E, Kuroda Y, Akaogi Y, Satoh M, et al. 2006. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). American Journal of Pathology, 4, 1227-1240. [21]Pober J S. 1988. Cytokine-mediated activation of vascular endothelium. American Journal of Pathology, 133, 426-433. [22]Pusztaszeri M P, Seelentag W, Bosman F T. 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von willebrand factor, and fli-1 in normal human tissues. Journal of Histochemistry and Cytochemistry, 4, 385-395. [23]Schumann R R, van der Bosch J, Ruller S, Ernst M, Schlaak M. 1989. Monocyte long-term cultivation on microvascular endothelial cell monolayers: morphologic and phenotypic characterization and comparison with monocytes cultured on tissue culture plastic. Blood, 73, 818-826. [24]Song D, Meng Q. 2009. Baicalin pharmacological effects commentary. Chinese Archives of Traditional Chinese Medicine, 8, 1619-1621. (in Chinese) [25]Xu G, Dou J, Zhang L, Guo Q, Zhou C. 2010. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biological and Pharmaceutical Bulletin, 2, 238-243. [26]Wei W Y, Kita M, Shinmura K, Yan X Q, Fukuyama R, Fushiki S, Imanishi J. 2000. Expression of IFN-gamma in cerebrovascular endothelial cells from aged mice. Journal of Interferon and Cytokine Research, 4, 403-409. [27]Wu Y, Jin Y, Wu J, Yu X, Hao Y. 2010. Antiviral effects of major constituents of huangqin (radix scutellariae) on influenza a virus (FM1) in vitro. Journal of Beijing University of Traditional Chinese Medicine, 8, 541-545. (in Chinese) |